Bevacizumab concomitant with chemotherapy is effective in treating Chinese patients with advanced non-squamous non-small cell lung cancer.

Sun, Jing; Hu, Yi; Wu, Bai-Shou; Wang, Jin-Liang; Tao, Hai-Tao; Zhang, Su-Jie

Sun, Jing; Hu, Yi; Wu, Bai-Shou; Wang, Jin-Liang; Tao, Hai-Tao; Zhang, Su-Jie.

Affiliation

Sun J; Department of Medical Oncology, Chinese PLA General Hospital, Beijing, China E-mail : huyi04010401@aliyun.com.

Asian Pac J Cancer Prev ; 15(14): 5945-50, 2014.

Article in En | MEDLINE | ID: mdl-25081727

Subject(s)

Angiogenesis Inhibitors/therapeutic use; Antibodies, Monoclonal, Humanized/therapeutic use; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Carcinoma, Non-Small-Cell Lung/drug therapy; Lung Neoplasms/drug therapy; Adult; Aged; Angiogenesis Inhibitors/adverse effects; Antibodies, Monoclonal, Humanized/adverse effects; Bevacizumab; Carcinoma, Non-Small-Cell Lung/mortality; China; Disease-Free Survival; Female; Humans; Lung Neoplasms/mortality; Male; Middle Aged; Retrospective Studies; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Carcinoma, Non-Small-Cell Lung / Angiogenesis Inhibitors / Antibodies, Monoclonal, Humanized / Lung Neoplasms Type of study: Observational_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: En Journal: Asian Pac J Cancer Prev Journal subject: NEOPLASIAS Year: 2014 Document type: Article Country of publication: Thailand

Search on Google

Add to My VHL

XML

PubMed Links